Page last updated: 2024-08-23

epirubicin and Central Nervous System Neoplasm

epirubicin has been researched along with Central Nervous System Neoplasm in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abali, H; Celik, I1
Bang, YJ; Ha, SW; Huh, DS; Kim, IH; Park, CI; Wu, HG1

Trials

1 trial(s) available for epirubicin and Central Nervous System Neoplasm

ArticleYear
Survival improvement with combined radio-chemotherapy in the primary central nervous system lymphomas.
    Journal of Korean medical science, 1999, Volume: 14, Issue:5

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Central Nervous System Neoplasms; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Epirubicin; Female; Humans; Lymphoma; Male; Mechlorethamine; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisolone; Procarbazine; Radiotherapy Dosage; Radiotherapy, Adjuvant; Survival Rate; Treatment Failure; Vincristine

1999

Other Studies

1 other study(ies) available for epirubicin and Central Nervous System Neoplasm

ArticleYear
High incidence of central nervous system involvement in patients with breast cancer treated with epirubicin and docetaxel.
    American journal of clinical oncology, 2002, Volume: 25, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Central Nervous System Neoplasms; Combined Modality Therapy; Docetaxel; Epirubicin; Female; Fluorouracil; Humans; Paclitaxel; Taxoids

2002